Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has results × Hyponatremia × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1013 Prostatic Neoplasms 555 Neoplasms 511 Multiple Myeloma 427 Carcinoma, Non-Small-Cell Lung 418 Leukemia, Myeloid, Acute 399 Leukemia 372 Lung Neoplasms 348 Lymphoma 335 Leukemia, Lymphocytic, Chronic, B-Cell 290 Precursor Cell Lymphoblastic Leukemia-Lymphoma 283 Lymphoma, Non-Hodgkin 278 Pancreatic Neoplasms 273 Neoplasm Metastasis 269 Colorectal Neoplasms 269 Myelodysplastic Syndromes 266 Melanoma 243 Hodgkin Disease 218 Head and Neck Neoplasms 213 Brain Neoplasms 207 Ovarian Neoplasms 199 Lymphoma, Follicular 197 Recurrence 196 Glioblastoma 195 Lymphoma, Mantle-Cell 189 Lymphoma, Large B-Cell, Diffuse 182 Squamous Cell Carcinoma of Head and Neck 151 Colonic Neoplasms 139 Carcinoma, Renal Cell 135 Carcinoma, Hepatocellular 135

Interventions

Tolvaptan 1 Sugars 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01199198 2020-09-23

Tolvaptan in Hyponatremic Cancer Patients

M.D. Anderson Cancer Center

Phase 4 Completed

52 enrolled 7 charts

Hyponatremia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡